Myasthenia Gravis News

November 18, 2020November 18, 2020
Latest NORD Webinar Offers Insights on Starting Nonprofit, Patient Registry
News, syndicated
Leaders in the U.S. rare disease community came together recently for a webinar to present helpful information on how ... Read more
November 17, 2020November 17, 2020
Dosing Begins in Phase 2 Trial of Mezagitamab, Antibody to Treat MG
News
A first person has been dosed in a Phase 2 trial evaluating mezagitamab (TAK-079), Takeda Pharmaceutical’s investigational antibody, as ... Read more
November 13, 2020November 13, 2020
Age, Type of Surgery Linked to Thymoma Relapse Risk in MG Patients
News
Among myasthenia gravis (MG) patients whose thymomas — tumors of the thymus — are surgically removed, those who are younger, have ... Read more
November 10, 2020November 11, 2020
Melatonin Supplements May Worsen MG Symptoms, Case Series Suggests
News
Melatonin supplements usually used to treat insomnia may aggravate the symptoms of myasthenia gravis (MG), possibly by activating the ... Read more
November 6, 2020November 6, 2020
Age at Disease Onset, Exercise Among Factors Seen to Affect Patients’ Life Quality
News
Quality of life tends to be poorer in people with myasthenia gravis (MG) who develop the disease later in ... Read more
November 4, 2020November 6, 2020
NORD Hosting ‘RareLaunch’ Workshops to Help Start Rare Disease Non-profits
News, syndicated
The National Organization for Rare Disorders (NORD)’s RareLaunch training program will host two days of free virtual workshops in ... Read more
November 3, 2020November 3, 2020
Local Corticosteroid Effective in Ocular MG, Small Study Finds
News
Local injections of the corticosteroid dexamethasone alleviated symptoms and resulted in complete remission in most patients with ocular myasthenia gravis, a ... Read more
October 30, 2020October 30, 2020
Low Levels of RNA Molecules in Thymus May Contribute to MG Development
News
An analysis of the thymuses removed from people with myasthenia gravis (MG) found lower levels of micro RNA molecules (miRNAs) ... Read more
October 27, 2020October 27, 2020
App-based MyRealWorld MG Study Seeks Patient Insights
News
Argenx is looking for participants in an app-based international study of the impact and burden of myasthenia gravis (MG) on ... Read more
October 26, 2020October 28, 2020
UK Organization ‘Same But Different’ Announces ‘Glimmer of Hope’ Photo Contest Winner
News, syndicated
A photo of a bespectacled young boy, his red baseball cap slightly askew as he enjoys time outside, will ... Read more
October 23, 2020October 23, 2020
gMG Symptoms May Worsen Severely After Stopping Soliris, Case Study Reports
News
A Japanese man with generalized myasthenia gravis (gMG) experienced a severe worsening of symptoms after discontinuing treatment with ... Read more
October 20, 2020October 20, 2020
Activating Bile Acid Receptor May Be Therapy Target for MG, Study Reports
News
Activating the bile acid receptor TGR5 was found to reduce the number of immune cells that secrete proinflammatory proteins, ... Read more

Latest NORD Webinar Offers Insights on Starting Nonprofit, Patient Registry

Dosing Begins in Phase 2 Trial of Mezagitamab, Antibody to Treat MG

Age, Type of Surgery Linked to Thymoma Relapse Risk in MG Patients

Melatonin Supplements May Worsen MG Symptoms, Case Series Suggests

Age at Disease Onset, Exercise Among Factors Seen to Affect Patients’ Life Quality

NORD Hosting ‘RareLaunch’ Workshops to Help Start Rare Disease Non-profits

Local Corticosteroid Effective in Ocular MG, Small Study Finds

Low Levels of RNA Molecules in Thymus May Contribute to MG Development

App-based MyRealWorld MG Study Seeks Patient Insights

UK Organization ‘Same But Different’ Announces ‘Glimmer of Hope’ Photo Contest Winner

gMG Symptoms May Worsen Severely After Stopping Soliris, Case Study Reports

Activating Bile Acid Receptor May Be Therapy Target for MG, Study Reports